公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2018 | Temporal trend and risk determinants of hepatocellular carcinoma in chronic hepatitis B patients on entecavir or tenofovir | Hsu Y.-C.; Ho H.-J.; Lee T.-Y.; Huang Y.-T.; MING-SHIANG WU ; Lin J.-T.; Wu C.-Y.; El-Serag H.B. | Journal of Viral Hepatitis | 31 | 29 | |
2016 | The temporal trends of incidence, treatment, and in-hospital mortality of acute myocardial infarction over 15 years in a Taiwanese population | Yin W.-H.; Lu T.-H.; Chen K.-C.; Cheng C.-F.; Lee J.-C.; Liang F.-W.; Huang Y.-T.; LI-TAN YANG | International Journal of Cardiology | 46 | 47 | |
2017 | Time-varying serum gradient of hepatitis B surface antigen predicts risk of relapses after off-NA therapy | Chien N.-H.; Huang Y.-T.; Wu C.-Y.; Chang C.-Y.; MING-SHIANG WU ; JIA-HORNG KAO ; Mo L.-R.; Tai C.-M.; Lin C.-W.; Yang T.-H.; Lin J.-T.; Hsu Y.-C. | BMC Gastroenterology | 8 | 5 | |
2021 | Treating toxic epidermal necrolysis with systemic immunomodulating therapies: A systematic review and network meta-analysis | Tsai T.-Y.; Huang I.-H.; Chao Y.-C.; Li H.; Hsieh T.-S.; Wang H.-H.; Huang Y.-T.; Chen C.-Y.; Cheng Y.-C.; PO-HSIU KUO ; Huang Y.-C.; YU-KANG TU | Journal of the American Academy of Dermatology | 55 | 50 | |
2008 | Upregulation of discoidin domain receptor 2 in nasopharyngeal carcinoma | Chua H.-H.; TE-HUEI YEH ; Wang Y.-P.; Huang Y.-T.; Sheen T.-S.; Lo Y.-C.; Chou Y.-C.; CHING-HWA TSAI | Head and Neck | 32 | 31 | |
2010 | Upregulation of interleukin-1 by Epstein-Barr virus latent membrane protein 1 and its possible role in nasopharyngeal carcinoma cell growth | Huang Y.-T.; Liu M.-Y.; CHING-HWA TSAI ; TE-HUEI YEH | Head and Neck | 9 | 10 | |
2007 | Using Taiwan's National Health Insurance research database for pharmacoepidemiology research | FEI-YUAN HSIAO ; Yang C.-L.; Huang Y.-T.; Huang W.-F. | Journal of Food and Drug Analysis | 126 | ||
2011 | Using the diamond model to prioritize 30 causes of death by considering both the level of and inequality in mortality | Lu T.-H.; Huang Y.-T.; TUNG-LIANG CHIANG | Health Policy | 2 | 2 | |
2007 | YC-1 inhibits HIF-1 expression in prostate cancer cells: Contribution of Akt/NF-κB signaling to HIF-1α accumulation during hypoxia | Sun H.-L.; Liu Y.-N.; Huang Y.-T.; Pan S.-L.; Huang D.-Y.; JIH-HWA GUH ; Lee F.-Y.; Kuo S.-C.; Teng C.-M. | Oncogene | 162 | 158 | |
2005 | YC-1 suppresses constitutive nuclear factor-κB activation and induces apoptosis in human prostate cancer cells | Huang Y.-T.; Pan S.-L.; JIH-HWA GUH ; Chang Y.-L.; Lee F.-Y.; Kuo S.-C.; Teng C.-M. | Molecular Cancer Therapeutics | 45 | 43 |